Mohamed A. Bayar

Villejuif, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Group sequential adaptive designs in series of time-to-event randomised trials in rare diseases: A simulation study.

Group sequential adaptive designs in series of time-to-event randomised trials in rare diseases: A simulation study.

Journal: Statistical methods in medical research
Published: July 30, 2019

Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer.

Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 27, 2019

Correction: ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors.

Correction: ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 17, 2019

CRM2DIM: A SAS macro for implementing the dual-agent Bayesian continual reassessment method.

CRM2DIM: A SAS macro for implementing the dual-agent Bayesian continual reassessment method.

Journal: Computer methods and programs in biomedicine
Published: February 09, 2019

No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer.

No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer.

Journal: BMC cancer
Published: December 15, 2018

A new prognostic model for survival in second line for metastatic renal cell carcinoma: development and external validation.

A new prognostic model for survival in second line for metastatic renal cell carcinoma: development and external validation.

Journal: Angiogenesis
Published: October 02, 2018

Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial.

Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 13, 2018

Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial.

Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial.

Journal: International journal of radiation oncology, biology, physics
Published: January 29, 2018

A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer.

A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 28, 2017

ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors.

ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 04, 2017

Statistical approaches for evaluating body composition markers in clinical cancer research.

Statistical approaches for evaluating body composition markers in clinical cancer research.

Journal: Expert review of anticancer therapy
Published: March 10, 2017

Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot study.

Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: December 26, 2016
Showing 1-12 of 16

Last Updated: 09/26/2026